AP-18 ≥98% TRPA1 receptor antagonist
Reversible TRPA1 receptor antagonist (IC₅₀ = 3,1 μM). Anti-inflammatory agent. Active in vivoand in vitro.
: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- :55224-94-7
- :209,67 g/mol
Reversible TRPA1 receptor antagonist (IC₅₀ = 3,1 μM). Anti-inflammatory agent. Active in vivoand in vitro.
: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- :55224-94-7
- :209,67 g/mol
- Constituents::100% AP-18
Product Family Options
unology General